Twenty Years of Neonatal Screening for Sickle Cell Disease in Brazil: The Challenges of a Continental Country with High Genetic Heterogeneity
暂无分享,去创建一个
[1] J. Xie,et al. Establishment and application of a novel method based on single nucleotide polymorphism analysis for detecting β-globin gene cluster deletions , 2020, Scientific Reports.
[2] A. Guddati,et al. Effect of immigration on mortality trends in sickle cell patients. , 2020, American journal of blood research.
[3] Carolina Mariano Pompeo,et al. Fatores de risco para mortalidade em pacientes com doença falciforme: uma revisão integrativa , 2020, Escola Anna Nery.
[4] A. Silva-Pinto,et al. The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD) , 2019, International journal of neonatal screening.
[5] M. Gladwin,et al. Pathophysiology of Sickle Cell Disease. , 2019, Annual review of pathology.
[6] B. Marcheco-Teruel,et al. Newborn Screening for Sickle Cell Disease in the Caribbean: An Update of the Present Situation and of the Disease Prevalence , 2019, International journal of neonatal screening.
[7] L. Vilarinho,et al. Newborn screening for sickle cell disease in Europe: recommendations from a Pan‐European Consensus Conference , 2018, British journal of haematology.
[8] D. Weatherall,et al. Sickle cell disease , 2018, Nature Reviews Disease Primers.
[9] B. Cauwelier,et al. Evaluation of four hemoglobin separation analyzers for hemoglobinopathy diagnosis , 2018, Journal of clinical laboratory analysis.
[10] C. Hoppe,et al. The pressing need for point-of-care diagnostics for sickle cell disease: A review of current and future technologies. , 2017, Blood cells, molecules & diseases.
[11] Paola Audicio,et al. Primeros resultados del Plan Piloto de Pesquisa Neonatal de Hemoglobinopatías en Uruguay: first results in Uruguay , 2017 .
[12] F. Piel,et al. Sickle Cell Disease. , 2017, The New England journal of medicine.
[13] C. Máximo,et al. Mortality from Sickle Cell Disease in Brazil , 2023, medRxiv.
[14] Sandra Johanna Echeverry-Coral,et al. Detecção de hemoglobinopatias por meio de um programa institucional de triagem neonatal na Colômbia , 2016 .
[15] M. Hutz,et al. The effects of old and recent migration waves in the distribution of HBB*S globin gene haplotypes , 2016, Genetics and molecular biology.
[16] R. Eller,et al. Evaluation of a neonatal screening program for sickle-cell disease. , 2016, Jornal de pediatria.
[17] M. Gonçalves,et al. Hemoglobin A2 values in sickle cell disease patients quantified by high performance liquid chromatography and the influence of alpha thalassemia , 2015, Revista brasileira de hematologia e hemoterapia.
[18] M. Viana,et al. Characterization of mortality in children with sickle cell disease diagnosed through the Newborn Screening Program. , 2015, Jornal de pediatria.
[19] Naresh Gupta,et al. HPLC in Characterization of Hemoglobin Profile in Thalassemia Syndromes and Hemoglobinopathies: A Clinicohematological Correlation , 2015, Indian Journal of Hematology and Blood Transfusion.
[20] D. Nathan,et al. Advances in Sickle Cell Therapies in the Hydroxyurea Era , 2014, Molecular medicine.
[21] I. Odame. Perspective: We need a global solution , 2014, Nature.
[22] S. Ballas,et al. Newborn screening program for hemoglobinopathies in Rio de Janeiro, Brazil , 2014, Pediatric blood & cancer.
[23] Liliete Canes Souza,et al. Prevalência de patologias detectadas pela triagem neonatal em Santa Catarina , 2013 .
[24] A. K. C. Nunes,et al. [Prevalence of disorders detected by newborn screening in Santa Catarina]. , 2013, Arquivos brasileiros de endocrinologia e metabologia.
[25] Dina N. Greene,et al. Comparison of Sebia Capillarys Flex capillary electrophoresis with the BioRad Variant II high pressure liquid chromatography in the evaluation of hemoglobinopathies. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[26] Ney Boa-Sorte,et al. AVALIAÇÃO DO PROGRAMA DE TRIAGEM NEONATAL DA BAHIA ENTRE 2007 E 2009 – AS LIÇÕES DA DOENÇA FALCIFORME , 2010 .
[27] K. Atkin,et al. Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial , 2010, BMJ : British Medical Journal.
[28] M. Hutz,et al. Neonatal screening for hemoglobinopathies: results of a public health system in South Brazil. , 2010, Genetic testing and molecular biomarkers.
[29] D. Diniz,et al. [Prevalence of sickle cell trait and sickle cell anemia among newborns in the Federal District, Brazil, 2004 to 2006]. , 2009, Cadernos de saude publica.
[30] Mara Albonei Dudeque Pianovski,et al. Prevalência da hemoglobina S no Estado do Paraná, Brasil, obtida pela triagem neonatal , 2008 .
[31] Mouseline T. Domingos,et al. [Prevalence of hemoglobin S in the State of Paraná, Brazil, based on neonatal screening]. , 2008, Cadernos de saude publica.
[32] M. Saborío,et al. [Abnormal haemoglobins in the newborn human population of Costa Rica]. , 2008, Revista de Biología Tropical.
[33] J. Braga. Medidas gerais no tratamento das doenças falciformes , 2007 .
[34] Manuel Saborío,et al. Hemoglobinas anormales en la población neonatal de Costa Rica , 2007 .
[35] Maria Luiza Bazzo,et al. Triagem neonatal como um problema de saúde pública , 2005 .
[36] M. Reis,et al. Hemoglobinopathies in newborns from Salvador, Bahia, Northeast Brazil. , 2005, Cadernos de saude publica.
[37] I. Hambleton,et al. Newborn screening for sickle cell disease in Brazil: the Campinas experience. , 2004, Clinical and laboratory haematology.
[38] Tereza Maria Dantas de Medeiros,et al. [Prevalence of abnormal hemoglobins in newborns in Natal, Rio Grande do Norte, Brazil]. , 2004, Cadernos de saude publica.
[39] F. Salzano,et al. Historical genetics: Spatiotemporal analysis of the formation of the Brazilian population , 2003, American journal of human biology : the official journal of the Human Biology Council.
[40] M. Viana,et al. RELIABILITY OF ISOELECTROFOCUSING FOR THE DETECTION OF Hb S, Hb C, AND Hb D IN A PIONEERING POPULATION-BASED PROGRAM OF NEWBORN SCREENING IN BRAZIL , 2001, Hemoglobin.